Evalution™ - the multiplexed analysis of biomarkers made fast and simple
Accelerate your research, trust your results Evalution™ is MyCartis’ multiplex analysis platform tailored to the development of clinical biomarkers. It has been designed to analyze a broad range of protein and nucleic- acid based biomarkers to deliver high quality data and rapid results from minimal handling steps with unprecedented ease. Evalution™ integrates into a single instrument all the functions of incubation, washing, and optical readout for seamless operation of sophisticated assay protocols. The combination of customizable encoded microparticles with microfluidic assay plates in Evalution™ enables the analysis of proteins, nucleic-acids or other biomarkers.
The platform Evalution is intended for research use only – Not for diagnostic procedure
The big revolution in healthcare today is that we are finally realizing that we are all equal, but not identical, certainly not at a molecular level. MyCartis is convinced that the future of healthcare lies in personalization. Our goal is to deliver innovative solutions for fast and cost effective identification of a patient’s specific signature of biomarkers in order to make more personal health decisions and improve quality of life. On our road to validate biomarkers on a larger scale, our intention is to build a bridge between research and medical practice by developing broadly available multiplexed biomarker solutions through technology (Evalution™) and bio-assays. The ability to quantify different types of markers on a single platform will help producing more comprehensive and coherent multiplex data sets.
MyCartis wants to help you to make your biomarkers a success. ‘Collaborate to Innovate’ is our motto and therefore we are looking forward to work with you and help you commercialize your products.